BamSEC and AlphaSense Join Forces
Learn More

Vor Biopharma Inc.

NASDAQ: VOR    
Share price (12/23/24): $0.87    
Market cap (12/23/24): $59.6 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 4 pages Material contract
12/34/56
EX-10.1
from 8-K 35 pages Vor Biopharma Inc. Amended and Restated 2021 Equity Incentive Plan Adopted by the Board of Directors: March 26, 2024 Approved by the Stockholders: May 23, 2024
12/34/56
EX-10
from 10-Q 3 pages Vor Biopharma Inc. Non-Employee Director Compensation Policy Effective: April 12, 2023
12/34/56
EX-10.1
from 8-K 34 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 10-Q 10 pages May 11, 2022 Christopher Slapak, M.D. via Docusign/Email Re: Separation Agreement Dear Christopher: This Letter Sets Forth the Substance of the Separation Agreement (Hereinafter, “Agreement”) That Vor Biopharma Inc. (Hereinafter, the “Company”) Is Offering to You to Aid in Your Employment Transition and Retirement From the Company. 1. Separation. Your Last Day of Employment Will Be May 6, 2022 (Hereinafter, the “Separation Date”). 2
12/34/56
EX-10.1
from 10-Q 6 pages Portions of This Agreement (Indicated by “[***]”) Have Been Omitted as the Registrant Has Determined That: (I) the Omitted Information Is Not Material; and (II) the Omitted Information Is the Type That the Registrant Treats as Private or Confidential. Second Amendment to Exclusive License Agreement
12/34/56
EX-10.2
from 8-K 27 pages Second Amendment to Lease
12/34/56
EX-10.1
from 8-K 20 pages First Amendment to Lease
12/34/56
EX-10.15
from S-1/A 13 pages Vor Biopharma Inc. Executive Severance and Change in Control Benefits Plan
12/34/56
EX-10.14
from S-1/A 2 pages Vor Biopharma Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.7
from S-1/A 11 pages Vor Biopharma Inc. 2021 Employee Stock Purchase Plan Adopted by the Board of Directors: January 28, 2021 Approved by the Stockholders: January 29, 2021
12/34/56
EX-10.6
from S-1/A 63 pages Vor Biopharma Inc. 2021 Equity Incentive Plan Adopted by the Board of Directors: January 28, 2021 Approved by the Stockholders: January 29, 2021
12/34/56
EX-10.13
from S-1 5 pages Tirtha Chakraboty Dear Tirtha, on Behalf of Vor Biopharma Inc. (“VOR” or the “Company”), We Are Thrilled to Offer You the Following
12/34/56
EX-10.12
from S-1 9 pages March 20, 2020 Dear Nathan, on Behalf of Vor Biopharma Inc. (“VOR” or the “Company”), We Are Thrilled to Offer You the Following
12/34/56
EX-10.11
from S-1 8 pages July 2, 2020 Dear Christopher, on Behalf of Vor Biopharma Inc. (“VOR” or the “Company”), We Are Thrilled to Offer You the Following
12/34/56
EX-10.10
from S-1 9 pages August 12, 2019 Dear Sadik, on Behalf of Vor Biopharma Inc. (“VOR” or the “Company”), We Are Thrilled to Offer You the Following
12/34/56
EX-10.9
from S-1 10 pages June 28, 2019 Dear Robert, on Behalf of Vor Biopharma Inc. (“VOR” or the “Company”), We Are Thrilled to Offer You the Following
12/34/56
EX-10.8
from S-1 16 pages Vor Biopharma Inc. Indemnification Agreement
12/34/56
EX-10.5
from S-1 64 pages Vor Biopharma Inc. 2015 Stock Incentive Plan
12/34/56
EX-10.4
from S-1 122 pages 100 Cambridgepark Drive Cambridge, Massachusetts Lease Between Ppf Off 100 Cambridge Park Drive, LLC, a Delaware Limited Liability Company (“Landlord”) and Vor Biopharma, Inc., a Delaware Corporation (“Tenant”) Dated as of December 17, 2019
12/34/56